These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2423993)
1. [Membrane and thyroglobulin antibodies in Graves-Basedow disease treated with I-131 or thyrostatics]. Czech W; Krzaścik E; Gardas A; Jastrzebska H; Bednarski A Pol Tyg Lek; 1986 Feb; 41(5):142-4. PubMed ID: 2423993 [No Abstract] [Full Text] [Related]
2. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options]. Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033 [TBL] [Abstract][Full Text] [Related]
3. [Reflections on the therapeutic goal in Basedow hyperthyroidism]. Höfer R Acta Med Austriaca; 1987; 14(3-4):70-2. PubMed ID: 2447737 [TBL] [Abstract][Full Text] [Related]
4. The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs. Huang CS; Tseng FY; Chang TC; Chang CC; Chen FW; Torng JK Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Nov; 16(4):277-82. PubMed ID: 6202467 [TBL] [Abstract][Full Text] [Related]
5. [Occurrence of various autoantibodies in autoimmune diseases]. Lacka K; Jarczewska K; Gembicki M Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):751-3, 770. PubMed ID: 2641801 [TBL] [Abstract][Full Text] [Related]
6. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease. Hopf U; Fiek T; Grün R; Zuschneid W J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440 [TBL] [Abstract][Full Text] [Related]
7. No prognostic value of thyroid autoantibodies changes during and after methimazole therapy in patients with Graves' disease. Lattanzi V; Ciampolillo A; Vincenti C; Giorgino R Boll Soc Ital Biol Sper; 1985 Apr; 61(4):507-13. PubMed ID: 3840026 [No Abstract] [Full Text] [Related]
8. [Personal experience in the study of thyroid autoimmunity and endocrine exophthalmos]. Winand R Bull Mem Acad R Med Belg; 1989; 144(5-7):363-70; discussion 370-2. PubMed ID: 2575920 [TBL] [Abstract][Full Text] [Related]
9. Studies on a receptor assay for an antibody to human thyroid plasma membrane. Ochi Y; Hosoda S; Hachiya T; Yoshimura M; Miyazaki T; Kajita Y Acta Endocrinol (Copenh); 1979 May; 91(1):89-98. PubMed ID: 582221 [No Abstract] [Full Text] [Related]
10. [The significance of microsomal antibodies, thyroglobulin antibodies, thyrotropin receptor antibodies in the diagnosis of thyroid diseases]. Horster FA Internist (Berl); 1988 Aug; 29(8):538-40. PubMed ID: 3053504 [No Abstract] [Full Text] [Related]
11. [The development of a radioimmunological method for determining autoantibodies to thyroglobulin]. Shcherban' AI; Cherkesova TS; Bogdanovich AF; Vasilevskiĭ VI; Demidchik EP; Minaĭlo TI Probl Endokrinol (Mosk); 1990; 36(3):72-5. PubMed ID: 2395841 [TBL] [Abstract][Full Text] [Related]
12. [Behavior of antithyroglobulin and antimicrosomal antibodies in thyroid pathology]. Sussi PL; Burro A; Plebani M; Abrescia F; Perazzolo E; Petronio R Chir Ital; 1984 Aug; 36(4):643-7. PubMed ID: 6549274 [TBL] [Abstract][Full Text] [Related]
13. [Diagnostic criteria in terminating therapy in Basedow hyperthyroidism]. Ogris E Acta Med Austriaca; 1987; 14(3-4):77-84. PubMed ID: 2447740 [TBL] [Abstract][Full Text] [Related]
14. Thyroid antibodies in Graves' disease. An immunofluorescence study. Szabó J; Leövey A Acta Med Hung; 1983; 40(2-3):91-7. PubMed ID: 6366729 [TBL] [Abstract][Full Text] [Related]
15. An investigation of pedigrees of 110 patients with Graves' disease and the clinical significance of determinations of antithyroid antibodies of their first-degree relatives. Wang DQ; Wang JZ; Ren JM; Zhou XT; Peng WC Chin Med J (Engl); 1994 Nov; 107(11):817-21. PubMed ID: 7867387 [TBL] [Abstract][Full Text] [Related]
16. Analysis of peripheral T lymphocyte subpopulations in Graves' disease. Okabe N; Inoue K; Mori R J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106 [TBL] [Abstract][Full Text] [Related]
17. Triiodothyronine autoantibodies in Graves' disease: their changes after antithyroid therapy and relationship with the thyroglobulin antibodies. Wang PW; Huang MJ; Liu RT; Chen CD Acta Endocrinol (Copenh); 1990 Jan; 122(1):22-8. PubMed ID: 1689529 [TBL] [Abstract][Full Text] [Related]
18. The evolution of the ophthalmopathy during antithyroid drug therapy and its relationship with serum thyroglobulin and antithyroglobulin antibody in patients with Basedow's disease. Bromberg N; Werner RS; Sgarbi JA; Werner MC; Romaldini JH Exp Clin Endocrinol; 1991 May; 97(2-3):354-7. PubMed ID: 1717300 [No Abstract] [Full Text] [Related]
19. [Autoimmune reactions in diffuse toxic goiter after treatment with radioactive iodine]. Mazepa MA; Parashchak AP; Tomashivskaia LV; Rypan VS; Ivano-Frankovsk Med Radiol (Mosk); 1976 Feb; 21(2):72-3. PubMed ID: 946323 [No Abstract] [Full Text] [Related]
20. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen. Baker JR; Saunders NB; Kaulfersch W; Burman KD J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]